Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reed Pavan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Retina (Philadelphia, Pa.)|November 15, 2011
Familial trends in a population with macular holesChristine Nichols Kay, Peter Reed Pavan, Laurie Buccina Small, et al.
American Journal of Ophthalmology|January 5, 2002
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapyDouglas A Jabs, Mark L Van Natta, John H Kempen, et al.
Ophthalmology|February 18, 2006
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose studyJeffrey S Heier, Andrew N Antoszyk, Peter Reed Pavan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Retina (Philadelphia, Pa.)|November 15, 2011
Familial trends in a population with macular holesChristine Nichols Kay, Peter Reed Pavan, Laurie Buccina Small, et al.
American Journal of Ophthalmology|January 5, 2002
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapyDouglas A Jabs, Mark L Van Natta, John H Kempen, et al.
Ophthalmology|February 18, 2006
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose studyJeffrey S Heier, Andrew N Antoszyk, Peter Reed Pavan, et al.
Pageof 1